Ain Holdings Inc. · TSE:9627

Ain — Q3 FY4/24 Earnings Presentation

19 slides from Ain's earnings presentation, March 2024

  1. Slide 1: FY4/24 3Q IR Presentation

    FY4/24 3Q IR PRESENTATION March 2024

  2. Slide 2: Results Overview

    Results Overview © AIN HOLDINGS INC. All Rights Reserved. 1

  3. Slide 3: Consolidated P/L

    Consolidated P/L Net sales increased 12.3% YoY and 1.3% against the plan due to favorable performance in both dispensing pharmacy business and cosmetic and drag store business. Ordinary profit increased 21.7% YoY and 7.2% against the plan due to increase of sales. FY4/23 3Q FY4/24 3Q FY4/24 3Q YoY Y

  4. Slide 4: Dispensing Pharmacy Business (Consolidated)

    Dispensing Pharmacy Business (Consolidated) Net sales increased 12.1% YoY and 1.4% against the plan due to the easing of restrictions on outpatient visits, and rise in prescription numbers and average price because of improvements in the capabilities of primary care functions. Segment profit increas

  5. Slide 5: Cosmetic and Drug Store Business (Consolidated)

    Cosmetic and Drug Store Business (Consolidated) Net sales up 21.6% YoY and 2.2% against the plan because customer numbers were firm amid a recovery in mobility for both domestic shoppers and overseas visitors, and average sales price rose due to a change in customer buying habits. Segment profit inc

  6. Slide 6: Consolidated B/S

    Consolidated B/S Net cash became ¥44,208 million and shareholders’ equity ratio became 54.7%. We are maintaining a sound financial structure. End-FY4/23 (¥ million) End-FY4/24 3Q (¥ million) Assets Liabilities and Net Assets Assets Liabilities and Net Assets Current Current Current assets 98,305 lia

  7. Slide 7: Assets

    Assets The balance of total assets increased ¥11,938 million from the end of the previous fiscal year because of increase in merchandise due to a rise in inventories of COVID-19 treatments, and an increase in buildings and structures due to the new store openings. (¥ million) End-FY4/23 3Q End-FY4/2

  8. Slide 8: Liabilities and Net Assets

    Liabilities and Net Assets Accounts payable increased ¥ 9,289 million due to increase in pharmaceutical purchasing and new store openings. Short-term and long-term borrowings decreased ¥ 3,142 million due to repayment of loans payable. (¥ million) End-FY4/23 3Q End-FY4/23 End-FY4/24 3Q Change Accoun

  9. Slide 9: FY4/24 Revised Plan (Consolidated)

    FY4/24 Revised Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 8.8% YoY and ordinary profit increase 13.3% YoY due to new store openings of 41 stores for dispensing pharmacy business and 6 stores for cosmetic and drug store business. FY4/23 FY4/24

  10. Slide 10: Review

    Review © AIN HOLDINGS INC. All Rights Reserved. 9

  11. Slide 11: Review (YoY)

    Review (YoY) Ordinary profit increased ¥2.7 billion YoY due to increase of net sales in dispensing pharmacy business and cosmetic and drug store business. Net sales Ordinary profit ¥263.9 billion → ¥296.3 billion +¥32.4 billion ¥12.3 billion → ¥15.0 billion +¥2.7 billion +21.7% +12.3% ■Dispensing Ph

  12. Slide 12: Review (Plan)

    Review (Plan) Ordinary profit increased ¥1.0 billion against the revised plan due to increase of net sales in dispensing pharmacy business and cosmetic and drug store business. Net sales Ordinary profit ¥292.5 billion → ¥296.3 billion +¥3.8 billion ¥14.0 billion → ¥15.0 billion ＋¥1.0 billion +1.3% +

  13. Slide 13: Expansion of top-line: store openings

    Expansion of top-line ■Dispensing Pharmacy Plan to open 41 pharmacies（Organic 21, M&A 20） ■Cosmetic and Drug Store Plan to open 6 stores ■ Plan and Results FY4/24 3Q FY4/24 Revised Plan Results Revised Plan Dispensing Pharmacy 24 25 41 Organic 14 14 21 Opening M&A 10 11 20 Cosmetic and drug store 6

  14. Slide 14: Revised plan

    Revised plan © AIN HOLDINGS INC. All Rights Reserved. 13

  15. Slide 15: FY4/24 Revised Plan (Dispensing Pharmacy Business)

    FY4/24 Revised Plan (Dispensing Pharmacy Business) The group revised the full-year consolidated financial forecasts because net sales of same stores and stores openings in the previous year expected to increase. Net sales were revised to ¥349,100 million, increased 8.6% YoY and 3.9% against the init

  16. Slide 16: FY4/24 Revised Plan (Cosmetic and Drug Store Business)

    FY4/24 Revised Plan (Cosmetic and Drug Store Business) The group revised the full-year consolidated financial forecasts because net sales expected to increase due to firm amid a recovery in mobility of customer numbers for same stores. Net sales were revised to ¥29,500 million, increased 14.9% YoY a

  17. Slide 17: FY4/24 Revised Plan (Consolidated)

    FY4/24 Revised Plan (Consolidated) The group forecasts net sales for the fiscal year ending April 30, 2024 increase 8.8% YoY and ordinary profit increase 13.3% YoY due to new store openings of 41 stores for dispensing pharmacy business and 6 stores for cosmetic and drug store business. FY4/23 FY4/24

  18. Slide 18: AIN Holdings Inc. Corporate Planning Division

    Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/corporate/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This d

  19. Slide 19: AIN GROUP

    AIN GROUP

Ain Holdings — Q3 FY4/24 Earnings Presentation on 6ix